Sealing the envelope - the HIV-1 envelope glycoproteins as targets for therapeutics and vaccines.
Rogier W
RW
Sanders
Ben
B
Berkhout
D016915:AIDS Vaccines / Q000276:immunology; D015483:HIV Antibodies / Q000627:therapeutic use; D023581:HIV Fusion Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control; D015497:HIV-1 / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D058990:Molecular Targeted Therapy; D054299:env Gene Products, Human Immunodeficiency Virus / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism
D016915:AIDS Vaccines; D015483:HIV Antibodies; D023581:HIV Fusion Inhibitors; D054299:env Gene Products, Human Immunodeficiency Virus